Aug 2, 2005

Vocational performance tests for brain-injured patients: a follow-up study

Die Rehabilitation
J Pössl, U Kursawe

Abstract

Work hardening programmes are suggested for brain-injured patients who were unemployed during the rehabilitation period or could not return to their previous job due to specific impairments. The aim of this vocational intervention is to obtain information about the chance of competitive re-employment and about potential obstacles preventing it. In 1994 the city of Munich has established opportunities to perform work hardening programmes in selected municipal work domains. Between 1994 and 1998, 28 patients from the neuropsychological department of the Munich-Bogenhausen municipal hospital underwent such an intervention. 18 persons could be contacted for structured telephone interviews addressing their work histories after discharge from the rehabilitation unit. Three former patients who had retired immediately after the work hardening intervention did not attempt to resume working. Among the remaining 15 patients, six were able to resume full-time competitive work at follow-up, four persons were still employed but had been forced to limit work demands, and five persons had retired. A positive course of reintegration was seen in three patients who received a special vocational support following the work hardening intervention at...Continue Reading

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Vocational Rehabilitation
Mild Traumatic Brain Injury
Outcomes Research
Performance Tests
Quality of Life
Client Satisfaction
Benefit-Risk Assessment
Impaired Health

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

IGA Glomerulonephritis

IgA glomerulonephritis is a chronic form of glomerulonephritis characterized by deposits of predominantly Iimmunoglobin A in the mesangial area. Discover the latest research on IgA glomerulonephritis here.

Cryogenic Electron Microscopy

Cryogenic electron microscopy (Cryo-EM) allows the determination of biological macromolecules and their assemblies at a near-atomic resolution. Here is the latest research.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

LRRK2 & Immunity During Infection

Mutations in the LRRK2 gene are a risk-factor for developing Parkinson’s disease. However, LRRK2 has been shown to function as a central regulator of vesicular trafficking, infection, immunity, and inflammation. Here is the latest research on the role of this kinase on immunity during infection.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Meningococcal Myelitis

Meningococcal myelitis is characterized by inflammation and myelin damage to the meninges and spinal cord. Discover the latest research on meningococcal myelitis here.

Alzheimer's Disease: MS4A

Variants within membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease by recent genome-wide association studies. Here is the latest research.